Cellular localization of receptors using antibodies visualized by light and dual labeling confocal microscopy

Methods in Molecular Biology

Volumn 897, Issue , 2012, Pages 239-260

  Davenport, Anthony P ^a   Kuc, Rhoda E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Antisera; Dual labeling; Gene deletion; Immunofluorescence; Knock out mice; Orphan receptors; Peroxidase antiperoxidase

Indexed keywords

ANTIGEN; CELL MARKER; ENDOTHELIN; EPITOPE; ANTISERUM; PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL SPECIFICITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE DELETION; HOMOZYGOTE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; MICROSCOPY; MICROTOME; MOUSE; NONHUMAN; NORTHERN BLOTTING; PEROXIDASE ANTIPEROXIDASE COMPLEX; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; FLUORESCENT ANTIBODY TECHNIQUE; GENE INACTIVATION; GENETICS; IMMUNOLOGY; LIGHT; METABOLISM; METHODOLOGY; PROTEIN TRANSPORT; STAINING;

ANIMALS; CELLS, CULTURED; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKOUT TECHNIQUES; HUMANS; IMMUNE SERA; LIGHT; MICE; MICROSCOPY, CONFOCAL; PROTEIN TRANSPORT; PROTEINS; STAINING AND LABELING;

EID: 84867295124     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-909-9_12     Document Type: Article

References (41)

1. Davenport AP, Maguire JJ (2006) Endothelin. Handb Exp Pharmacol 176(Pt 1):295-329
2. Davenport AP (2002) International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54:219-226
3. Vachiery JL, Davenport A (2009) The endothe-lin system in pulmonary and renal vasculopa-thy: les liaisons dangereuses. Eur Respir Rev 18:260-271
4. Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, Gulliver-Sloan FH, Maguire JJ, Davenport AP, Kotelevtsev YV, Webb DJ (2010) Endothelial cell-speci fic ETB receptor knockout: autoradiographic and his-tological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol 88:644-651
5. Bagnall AJ, Kelland NF, Gulliver-Sloan F, Davenport AP, Gray GA, Yanagisawa M, Webb DJ, Kotelevtsev YV (2006) Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension 48:286-293
6. Kuc R, Davenport AP (2004) Comparison of endothelin-A and endothelin-B receptor distribution visualized by radioligand binding versus immunocytochemical localization using subtype selective antisera. J Cardiovasc Pharmacol 44(Suppl 1):S224-S226
7. Kuc RE, Maguire JJ, Davenport AP (2006) Quanti fication of endothelin receptor subtypes in peripheral tissues reveals downregulation of ET(A) receptors in ET(B)-de ficient mice. Exp Biol Med (Maywood) 231:741-745
8. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M, Harmar AJ (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57:279-288
9. Ozawa A, Lindberg I, Roth B, Kroeze WK (2010) Deorphanization of novel peptides and their receptors. AAPS J 12:378-384
10. Wise A, Jupe SC, Rees S (2004) The identi fication of ligands at orphan G-protien coupled receptors. Annu Rev Pharmacol Toxicol 44:43-66
11. Katugampola S, Davenport AP (2003) Emerging roles for orphan G protein-coupled receptors in the cardiovascular system. Trends Pharmacol Sci 24:30-35
12. Davenport AP (2003) Peptide and trace amine orphan receptors: prospects for new therapeutic targets. Curr Opin Pharmacol 3:127-134
13. Maguire JJ, Kuc RE, Davenport AP (2000) Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br J Pharmacol 131:441-446
14. Maguire JJ, Davenport AP (2002) Is urotensin-II the new endothelin? Br J Pharmacol 137:579-588
15. Mead EJ, Maguire JJ, Kuc RE, Davenport AP (2007) Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosis-prone vessels. Endocrinology 148:140-147
16. Maguire JJ, Kirby HR, Mead EJ, Kuc RE, de d'Anglemont Tassigny X, Colledge WH, Davenport AP (2011) Potent Inotropic Actions of the Puberty Hormone Kisspeptin in Rat, Mouse and Human: Cardiovascular Distribution and Characteristics of the Kisspeptin Receptor. PLOS 16(11):e27601
17. Mead EJ, Maguire JJ, Kuc RE, Davenport AP (2007) Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. Br J Pharmacol 151:1143-1153
18. Kirby HR, Maguire JJ, Colledge WH, Davenport AP (2010) International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function. Pharmacol Rev 62: 565-578
19. Mitchell JD, Maguire JJ, Kuc RE, Davenport AP (2009) Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system. Cardiovasc Res 81:353-361
20. Mitchell JD, Maguire JJ, Davenport AP (2009) Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. Br J Pharmacol 158: 87-103
21. Singh G, Maguire JJ, Kuc RE, Fidock M, Davenport AP (2004) Identi fication and cellular localisation of NPW1 (GPR7) receptors for the novel neuropeptide W-23 by (125I)-NPW radioligand binding and immunocytochemis-try. Brain Res 1017:222-226
22. Singh G, Davenport AP (2006) Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system. Br J Pharmacol 148:1033-1041
23. Kleinz MJ, Skepper JN, Davenport AP (2005) Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 126:233-240
24. Pitkin SL, Maguire JJ, Kuc RE, Davenport AP (2010) Modulation of the apelin/APJ system in heart failure and atherosclerosis in man. Br J Pharmacol 160:1785-1795
25. Maguire JJ, Kleinz MJ, Pitkin SL, Davenport AP (2009) (Pyr1)apelin-13 identi fied as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease. Hypertension 54:598-604
26. Macaluso NJ, Pitkin SL, Maguire JJ, Davenport AP, Glen RC (2011) Discovery of a competitive apelin receptor (APJ) antagonist. ChemMedChem 6:1017-1023
27. Kleinz MJ, Davenport AP (2005) Emerging roles of apelin in biology and medicine. Pharmacol Ther 107:198-211
28. Pitkin SL, Maguire JJ, Bonner TI, Davenport AP (2010) International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacol Rev 62:331-342
29. Davenport AP, Kuc RE (2000) Cellular expression of isoforms of endothelin-converting enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and endothelin-converting enzyme-2. J Cardiovasc Pharmacol 36:S12-S14
30. Davenport AP, Morton AJ (1991) Binding sites for 125 I ET-1, ET-2, ET-3 and vasoactive intestinal contractor are present in adult rat brain and neurone-enriched primary cultures of embryonic brain cells. Brain Res 554: 278-285
31. Russell FD, Skepper JN, Davenport AP (1997) Detection of endothelin receptors in human coronary artery vascular smooth muscle cells but not endothelial cells by using electron microscope autoradiography. J Cardiovasc Pharmacol 29:820-826
32. Baker SJ, Morris JL, Gibbins IL (2003) Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system. Brain Res Mol Brain Res 111:136-147
33. Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG (2002) Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 22:620-629
34. Hipser C, Bushlin I, Gupta A, Gomes I, Devi LA (2010) Role of antibodies in developing drugs that target G-protein-coupled receptor dimers. Mt Sinai J Med 77:374-380
35. Gupta A, Decaillot FM, Gomes I, Tkalych O, Heimann AS, Ferro ES, Devi LA (2007) Conformation state-sensitive antibodies to G-protein-coupled receptors. J Biol Chem 282:5116-5124
36. Schulte G (2010) International Union of Basic and Clinical Pharmacology LXXX. The class Frizzled receptors. Pharmacol Rev 62:632-667
37. Lum AM, Wang BB, Beck-Engeser GB, Li L, Channa N, Wabl M (2010) Orphan receptor GPR110, an oncogene overexpressed in lung and prostate cancer. BMC Cancer 10:40
38. Tazoe H, Otomo Y, Kaji I, Tanaka R, Karaki SI, Kuwahara A (2008) Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J Physiol Pharmacol 59(Suppl 2):251-262
39. D'Orleans-Juste P, Honore J-C, Carrier E, Labonte J (2003) Cardiovascular diseases: new insights from knockout mice. Curr Opin Pharmacol 3:181-185
40. Kurihara H, Kurihara J, Yazaki Y (2001) Lessons from gene deletion of endothelin systems. Hdbk Exp Pharmacol 152:141-154
41. Michel MC, Wieland T, Tsujimoto G (2009) How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379:385-388